T-cell Therapy Market Report, By Modality (Research and Commercialized), Therapy (CAR T-cell Based, T Cell Receptor (TCR) Based and Tumor Infiltrating Lymphocytes (TIL) Based), Indication (Hematologic Malignancies, Solid Tumors and Others), End-Users and Geography – Global Market Share, Trend Analysis & Forecast Up To 2030

T-cell Therapy Market Trend

Increased strategic investments by private as well as public agencies, technological advancements in the field of T-cell Therapy and rising product approval along with increasing manufacturing capacities are some of the major factors propelling the T-cell Therapy market globally. Furthermore, rising incidence of infectious diseases and increasing frequency of pandemics is also one of the factor propelling the growth of T-cell Therapy market. However, side effects of CAR T-cell Therapy systems is one of the major factor expected to hamper the global growth of the market.

T-cell Therapy Market Segmentation

The T-cell Therapy market is segmented by Modality, Therapy, Indication, End-Users and geography. The Modality studied in the T-cell Therapy market are Research and Commercialized. Furthermore, the Therapy comprises of CAR T-cell Based, T Cell Receptor (TCR) Based and Tumor Infiltrating Lymphocytes (TIL) Based. Moreover, the Indication includes Hematologic Malignancies, Solid Tumors and Others. In addition, various End-Users of T-cell Therapy are Hospitals, Specialty Clinics, Homecare and Others. Based on Geography, the T-cell Therapy market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.

T-cell Therapy Market by Geography

Based on geography, the T-cell Therapy market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global T-cell Therapy market. Major drivers include growing various technological advancements, the presence of major players, expansion of the healthcare sector and large number of clinical studies being done for T-cell therapies nationwide.

T-cell Therapy Market Report Key Benefits

• The report offers changing market dynamics in the T-cell Therapy market, presenting historical, current and projected market size in terms of value (USD Million)

• The report comprises a detailed analysis of the factors that drive and restrict the growth of global T-cell Therapy market.

• The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of T-cell therapy

• It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the T-cell Therapy market performance

• Key players within the global T-cell Therapy market are profiled to understand the competitor scenario.

T-cell Therapy Market Key Players

Some of the major players operating in the global T-cell Therapy market includes Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Merck KGaA, Aurora Health Care, bluebird bio, Inc., Amgen Inc., Gilead Sciences, Inc., Aurora Biopharma., Fate Therapeutics, Mustang Bio, Sorrento Therapeutics Inc., TCR² Therapeutics, Bayer AG, Bellicum Pharmaceuticals Inc., AstraZeneca and Johnson & Johnson Private Limited.

Research Objectives of T-cell Therapy Market Report